[ Price : $8.95]
FDA posts a final guidance entitled Enforcement Policy for Viral Transport Media During the Coronavirus Disease 2019 Public Health...[ Price : $8.95]
AstraZeneca reports positive interim data from an the ongoing Phase 1-2 COV001 trial, which showed that its AZD1222 vaccine was to...[ Price : $8.95]
Federal Register notice: FDA withdraws a notice of opportunity for a hearing that proposed to withdraw the approved uses of carbad...[ Price : $8.95]
Federal Register notice: FDA proposes an order to revoke the approved method for detecting residues of carbadox, a carcinogenic ne...[ Price : $8.95]
Federal Register notice: FDA announces an 8/18-19 Science Advisory Board to the National Center for Toxicological Research meeting...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Use of Real-World Data and Real-World Evidence to Support E...[ Price : $8.95]
Federal Register notice: FDA announces it is revoking approval of an Eli Lilly BLA for Lartruvo (olaratumab), indicated for combin...[ Price : $8.95]
FDA sends a Warning Letter to the operators of www.pharmaboosters.com over marketing unapproved and misbranded drugs.